2025-09-28 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the provided data, presented in English, with a focus on key numbers and concise analysis.

## Procter & Gamble (PG) Stock Analysis

**Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation that manufactures and markets a wide range of branded consumer products.

### 1. Performance vs. S&P 500 (VOO)

*   **PG Cumulative Return:** 23.01%
*   **VOO Cumulative Return:** 66.41%
*   **Absolute Divergence (Current):** -38.3%
*   **Relative Divergence:** 1.4

**Analysis:** PG has significantly underperformed the S&P 500 over the period. The relative divergence of 1.4 indicates that PG is currently near the lower end of its historical divergence range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B)  |
|------------|---------|---------|---------|--------|---------|
| 2015-2017  | 19.0%   | 56.3%   | 10.0%   | 0.2    | 215.0   |
| 2016-2018  | 7.0%    | 67.1%   | 8.0%    | 0.2    | 215.1   |
| 2017-2019  | 16.0%   | 70.5%   | 11.0%   | -0.1   | 292.3   |
| 2018-2020  | 20.0%   | 78.7%   | -6.0%   | 0.1    | 325.7   |
| 2019-2021  | 33.0%   | 78.7%   | 4.0%    | 0.5    | 382.9   |
| 2020-2022  | 12.0%   | 79.4%   | -2.0%   | 0.5    | 354.7   |
| 2021-2023  | 23.0%   | 79.4%   | 6.0%    | 0.5    | 343.0   |
| 2022-2024  | 6.0%    | 79.4%   | -6.0%   | 0.4    | 392.4   |
| 2023-2025  | -11.0%  | 80.1%   | -46.0%  | 0.2    | 356.9   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) has varied significantly, with a recent decline.
*   **MDD:** The Maximum Drawdown (MDD) has been consistently high, indicating substantial risk.
*   **Alpha:** Alpha has fluctuated, with negative values in recent periods, suggesting underperformance relative to the market.
*   **Beta:** Beta values are generally low, indicating lower volatility than the market.
*   **Cap(B):** Market capitalization has shown fluctuations.

### 2. Recent Price Action

*   **Current Price:** 152.5
*   **Previous Close:** 152.15
*   **Change:** 0.23
*   **5-day Moving Average:** 152.52
*   **20-day Moving Average:** 156.77
*   **60-day Moving Average:** 156.09

**Analysis:** The stock price is currently below both its 20-day and 60-day moving averages, suggesting a short-term downtrend. The recent change is slightly positive.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 31.58 (Approaching Oversold)
*   **PPO:** -0.49
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (6 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Delta_Previous_Relative_Divergence:** -1.2 (Short-term Decrease)
*   **Expected Return (%):** -137.3%

**Analysis:**

*   The MRI suggests the investment is in the High Investment Recommended zone, while the RSI indicates the stock may be approaching oversold conditions, potentially signaling a buying opportunity.
*   The negative PPO value confirms the downtrend, and the negative change in relative divergence indicates recent underperformance.
*   The significantly negative Expected Return suggests potential underperformance compared to the S&P 500 in the long term.
*   The Hybrid Signal recommends buying using all available cash.

### 4. Recent News & Significant Events

*   **[2025-09-27]** Simply Wall St.: Assessing Valuation After a Steady Year-Long Decline.
*   **[2025-09-26]** Business Wire: P&G to Webcast Discussion of First Quarter 25/26 Earnings Results on October 24.
*   **[2025-09-26]** Zacks:  2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar.
*   **[2025-09-26]** StockStory: 1 Safe-and-Steady Stock with Exciting Potential and 2 That Underwhelm.
*   **[2025-09-25]** Exec Edge: New Speakers Announced: 5th Palm Beach CorpGov Forum | Preview Panelists & Topics.
*   **[2025-09-25]** Business Wire: All Roads Lead to Oz: Olay Body and Secret Unveil Limited-Edition Wicked: For Good Collection

**Analysis:** The news headlines present a mixed picture. Some articles focus on potential undervaluation after a decline, while others highlight upcoming earnings discussions and identify PG as a potentially outperforming consumer staples stock. The product-related news indicates ongoing marketing efforts.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean Rating: 2.04)
*   **Target Price:** 170.82 (Average), 186.00 (High), 147.00 (Low)
*   **Recent Rating Changes:** No changes available.

**Analysis:** Analyst consensus is a "Buy" with an average target price significantly above the current price, suggesting potential upside.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-04-24 | 1.58 | 19.78 B$      |
| 2025-01-22 | 1.94 | 21.88 B$      |
| 2024-10-18 | 1.65 | 21.74 B$      |
| 2024-04-19 | 1.56 | 20.20 B$      |
| 2025-04-24 | 1.56 | 20.20 B$      |

**Analysis:**  Earnings per share (EPS) and revenue have fluctuated over the past few quarters.  It is important to verify if "2025-04-24" date is duplicated.

### 6. Financial Information

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $20.89B  | 49.11%        |
| 2025-03-31   | $19.78B  | 50.98%        |
| 2024-12-31   | $21.88B  | 52.39%        |
| 2024-09-30   | $21.74B  | 52.06%        |
| 2024-06-30   | $20.53B  | 49.60%        |

| Quarter      | Equity   | ROE     |
|--------------|----------|---------|
| 2025-06-30   | $52.01B  | 6.95%   |
| 2025-03-31   | $52.27B  | 7.21%   |
| 2024-12-31   | $51.17B  | 9.05%   |
| 2024-09-30   | $51.84B  | 7.64%   |
| 2024-06-30   | $50.29B  | 6.24%   |

**Analysis:**

*   **Revenue:** Revenue has shown some fluctuation but is generally stable.
*   **Profit Margin:** Profit margins have been relatively consistent, hovering around 50%.
*   **Equity:** Equity has remained fairly stable.
*   **ROE:** Return on Equity (ROE) has fluctuated, with a recent decrease.

### 7. Overall Summary

Based on the provided data, PG has underperformed the S&P 500 significantly. Recent price action suggests a short-term downtrend, although the RSI indicates it may be approaching oversold conditions. Analyst consensus is positive, but the expected return is concerning. The company's financials show stable revenue and profit margins, but ROE has declined. Recent news articles present a mixed view of the company's prospects.

**In conclusion, while analyst opinions and the MRI suggest a potentially safe investment, the underperformance relative to the market and negative expected return warrant caution. Further research and consideration of individual investment goals are recommended.**
